EUVIMEDEUVIMED entdecken
Fallbericht

CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease

Uroosa Ibrahim, Claude Bassil, Julio C Chavez, Farhad Khimani, Michael D Jain, Frederick L Locke, Keren Osman, Aleksandr Lazaryan

Clinical Lymphoma Myeloma and Leukemia · 2023-10 · 23 (10) · 772-778

DOI: 10.1016/j.clml.2023.05.007 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2023-10. Verfasst von Uroosa Ibrahim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplant and Cellular Therapy/Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New…. Hauptthemen laut MEDLINE: Organ Transplantation, Kidney Transplantation, Lymphoproliferative Disorders, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organ TransplantationKidney TransplantationLymphoproliferative DisordersEpstein-Barr Virus InfectionsHumansImmunotherapy, AdoptiveRare Diseases

Stichwörter der Autor:innen

Cellular therapyDiffuse large B cell lymphomaLiver transplantOrgan rejectionRenal transplant

Autor:innen und Institutionen

  • Bone Marrow Transplant and Cellular Therapy/Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY. Electronic address: uroosa.ibrahim@mssm.edu.
  • Department of Onconephrology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Bone Marrow Transplant and Cellular Therapy/Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY.

Zitieren

APA

Ibrahim, U., Bassil, C., Chavez, J. C., Khimani, F., Jain, M. D., Locke, F. L., Osman, K., & Lazaryan, A. (2023). CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease. Clinical Lymphoma Myeloma and Leukemia, 23(10), 772-778. https://doi.org/10.1016/j.clml.2023.05.007

Vancouver

Ibrahim U, Bassil C, Chavez JC, Khimani F, Jain MD, Locke FL, et al. CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease. Clinical Lymphoma Myeloma and Leukemia. 2023;23(10):772-778. doi:10.1016/j.clml.2023.05.007

BibTeX
@article{Ibrahim2023,
  author = {Ibrahim, Uroosa and Bassil, Claude and Chavez, Julio C and Khimani, Farhad and Jain, Michael D and Locke, Frederick L and Osman, Keren and Lazaryan, Aleksandr},
  title = {CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2023},
  volume = {23},
  number = {10},
  pages = {772--778},
  doi = {10.1016/j.clml.2023.05.007}
}
Kostenlos starten →